NEW YORK (MarketWatch) -- Mylan Laboratories Inc. said Tuesday that it received final approval from the Food and Drug Administration for its abbreviated new drug application for Glimepiride tablets, a ...
Nov. 11, 2005 — The U.S. Food and Drug Administration (FDA) has approved first-time generic formulations of glimepiride 1-, 2-, and 4-mg tablets and first-time doses of 3-, 6-, and 8-mg tablets for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results